Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why Dexamethasone Poorly Penetrates in Brain

De Kloet ER1

  • 1Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Medical Faculty, Leiden University, P.O. Box 9503, 2300 RA Leiden, The Netherlands.

Stress (Amsterdam, Netherlands)
|October 27, 1998
PubMed
Summary

Dexamethasone poorly enters the brain due to efflux by P-glycoproteins. This synthetic steroid primarily acts on the pituitary, potentially disrupting brain glucocorticoid receptor balance and neuronal health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent, but Paradoxical, Effects on HPA Regulation of Infants Maternally Deprived at Different Ages.

Stress (Amsterdam, Netherlands)·1997
Same author

Dexamethasone Does Not Prevent Seven-Day ADX-Induced Apoptosis in the Dentate Gyrus of the Rat Hippocampus.

Stress (Amsterdam, Netherlands)·1996
See all related articles

Area of Science:

  • Neuroendocrinology
  • Molecular Pharmacology

Background:

  • Dexamethasone, a synthetic glucocorticoid, poorly penetrates the brain.
  • Pituitary corticotrophs effectively retain dexamethasone, suggesting a primary site of action.

Purpose of the Study:

  • To investigate the mechanism of dexamethasone brain penetration and its implications for glucocorticoid receptor signaling.
  • To determine the role of P-glycoproteins in limiting brain uptake of dexamethasone.

Main Methods:

  • Administration of tracer amounts of [3H]-dexamethasone to adrenalectomized rats and mice.
  • Comparison of brain and pituitary uptake in wild-type versus mdr1a gene-disrupted mice.

Main Results:

  • Adrenalectomized mice lacking the mdr1a gene showed a tenfold increase in brain dexamethasone uptake.
  • Dexamethasone is actively extruded from the brain by mdr1a-encoded P-glycoproteins.
  • Chronic dexamethasone treatment disrupts the balance of mineralocorticoid and glucocorticoid receptors in the hippocampus.

Conclusions:

  • Dexamethasone's primary action is likely at the pituitary level for blocking ACTH release.
  • Brain P-glycoproteins limit dexamethasone's central effects, meaning it cannot replace endogenous corticosteroids.
  • Impaired glucocorticoid receptor balance in the hippocampus due to dexamethasone threatens neuronal integrity.

Related Experiment Videos